We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+8.36%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.58B
AUM Growth
+$568M
Cap. Flow
+$189M
Cap. Flow %
3.39%
Top 10 Hldgs %
17.58%
Holding
1,590
New
158
Increased
732
Reduced
501
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 17.89%
2 Financials 10.71%
3 Healthcare 10.59%
4 Consumer Discretionary 9.99%
5 Industrials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPG icon
276
PPG Industries
PPG
$24.9B
$4.83M 0.09%
28,478
-7,933
-22% -$1.36M
HACK icon
277
Amplify Cybersecurity ETF
HACK
$2.64B
$4.76M 0.09%
78,434
+2,707
+4% +$157K
ADI icon
278
Analog Devices
ADI
$179B
$4.73M 0.08%
27,492
+1,703
+7% +$273K
XLV icon
279
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$4.71M 0.08%
37,390
+9,472
+34% +$1.16M
CBRE icon
280
CBRE Group
CBRE
$43.3B
$4.68M 0.08%
54,581
-1,550
-3% -$132K
EOG icon
281
EOG Resources
EOG
$77.5B
$4.63M 0.08%
55,534
-46
-0.1% -$3.64K
KEYS icon
282
Keysight
KEYS
$53.4B
$4.58M 0.08%
29,656
+25
+0.1% +$3.63K
JCI icon
283
Johnson Controls International
JCI
$87.2B
$4.49M 0.08%
65,488
+9,888
+18% +$638K
CMI icon
284
Cummins
CMI
$87.3B
$4.49M 0.08%
18,403
+4,119
+29% +$1.05M
AYI icon
285
Acuity Brands
AYI
$10.1B
$4.48M 0.08%
23,974
-1,289
-5% -$234K
CQQQ icon
286
Invesco China Technology ETF
CQQQ
$2.99B
$4.48M 0.08%
53,208
+918
+2% +$74.4K
IWP icon
287
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
$4.48M 0.08%
39,570
+2,820
+8% +$301K
FITB
288
Fifth Third Bancorp
FITB
$51.3B
$4.48M 0.08%
117,071
-10,278
-8% -$411K
SHOP icon
289
Shopify
SHOP
$159B
$4.47M 0.08%
30,570
+7,200
+31% +$887K
CHKP icon
290
Check Point Software Technologies
CHKP
$13.1B
$4.42M 0.08%
38,090
-864
-2% -$102K
DXCM icon
291
DexCom
DXCM
$28.8B
$4.42M 0.08%
41,364
+2,848
+7% +$274K
VMC icon
292
Vulcan Materials
VMC
$35.1B
$4.4M 0.08%
25,293
-18,164
-42% -$3.25M
CL icon
293
Colgate-Palmolive
CL
$73.3B
$4.38M 0.08%
53,834
-908
-2% -$74.2K
DHR icon
294
Danaher
DHR
$138B
$4.37M 0.08%
18,377
-3,728
-17% -$827K
VEA icon
295
Vanguard FTSE Developed Markets ETF
VEA
$230B
$4.36M 0.08%
84,650
+4,358
+5% +$225K
HCA icon
296
HCA Healthcare
HCA
$85.7B
$4.34M 0.08%
20,988
+603
+3% +$123K
XLB icon
297
State Street Materials Select Sector SPDR ETF
XLB
$8.71B
$4.31M 0.08%
104,824
+12,530
+14% +$528K
OBDC icon
298
Blue Owl Capital
OBDC
$5.36B
$4.3M 0.08%
301,438
+125,837
+72% +$1.81M
WH icon
299
Wyndham Hotels & Resorts
WH
$5.65B
$4.28M 0.08%
59,186
+297
+0.5% +$21.9K
GSK icon
300
GSK
GSK
$104B
$4.27M 0.08%
85,868
+2,658
+3% +$128K

Similar funds

Oppenheimer & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Oppenheimer & Co held 1,590 positions worth $5.58B, up 11% from $5.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co deployed $189M of net new capital in Q2 2021, opening 158 new positions and adding to 732 existing holdings. Its largest new stake was Equity Commonwealth: 133,173 shares worth $3.49M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg Convertible Securities ETF, an estimated $8.63M trimmed.

  • Oppenheimer & Co's largest Q2 2021 buy was Equity Commonwealth: 133,173 shares worth $3.49M.
  • Oppenheimer & Co added most to Amazon in Q2 2021, an estimated $10.8M increase.
  • Oppenheimer & Co's biggest Q2 2021 reduction was State Street SPDR Bloomberg Convertible Securities ETF, cutting an estimated $8.63M.
  • Oppenheimer & Co fully exited Armstrong World Industries in Q2 2021, selling an estimated $7.38M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.58B portfolio in Q2 2021.
  • Oppenheimer & Co opened 158 new positions and closed 88 in Q2 2021.
  • Oppenheimer & Co's portfolio value rose 11% quarter-over-quarter to $5.58B.

Based on Oppenheimer & Co's 13F filing for Q2 2021, filed 3 Aug 2021.